K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (compound 25)

K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (compound 25) Descriptor: (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, (4S)-2-METHYL-2,4-PENTANEDIOL, DNA (5'-D(*GP*AP*TP*CP*AP*TP*AP*CP*AP*AP*CP*GP*TP*AP*A)-3'), ... Authors: Noeske, J, Shu, W, Bellamacina, C. Deposit date: 2021-01-26 Release date: 2021-05-12 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (3.3 Å) Cite: Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria. J.Med.Chem., 64, 2021

肺炎克雷伯菌（K. pneumoniae）的拓扑异构酶IV（Topoisomerase IV，ParE-ParC）与DNA以及(3S)-10-[(3R)-3-(1-氨基环丙基)吡咯烷-1-基]-9-氟-3-甲基-5-氧代-2,3-二氢-5H-[1,4]恶嗪并[2,3,4-ij]喹啉-6-羧酸（化合物25）形成的复合物。
描述符：(3S)-10-[(3R)-3-(1-氨基环丙基)吡咯烷-1-基]-9-氟-3-甲基-5-氧代-2,3-二氢-5H-[1,4]恶嗪并[2,3,4-ij]喹啉-6-羧酸、(4S)-2-甲基-2,4-戊二醇、DNA（5'-D(*GP*AP*TP*CP*AP*TP*AP*CP*AP*AP*CP*GP*TP*AP*A)-3'）等。
作者：Noeske J、Shu W、Bellamacina C。
沉积日期：2021-01-26
发布日期：2021-05-12
最后修改日期：2023-10-18
实验方法：X射线衍射（X-RAY DIFFRACTION），分辨率3.3埃（Å）
引用文献：《对氟喹诺酮耐药革兰阳性菌具有强效活性的DNA促旋酶与拓扑异构酶IV抑制剂的发现与优化》，《药物化学杂志》（J.Med.Chem.），第64卷，2021年